Enhancement of apixaban's solubility and dissolution rate by inclusion complex (β-cyclodextrin and hydroxypropyl β-cyclo¬dextrin) and computational calculation of their inclusion complexes
Background and Purpose: Apixaban (AP) is a factor X inhibitor, an orally active drug that inhibits blood coagulation for better prevention of venous thromboembolism. It has poor solubility, dissolution rate and low bioavailability. The aim of this study was to improve the aqueous solubility and diss...
Saved in:
Main Authors: | Zainab N. Salman (Author), Israa Al-Ani (Author), Khaldun M. Al Azzam (Author), Bashar JM. Majeed (Author), Hassan H. Abdallah (Author), El-Sayed Negim (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib
by: Bashar J. M. Majeed, et al.
Published: (2024) -
Formation of inclusion complex of enrofloxacin with 2-hydroxypropyl-β-cyclodextrin
by: Yili Ding, et al.
Published: (2020) -
Enhancement of norfloxacin solubility via inclusion complexation with β-cyclodextrin and its derivative hydroxypropyl-β-cyclodextrin
by: Gabriel Onn Kit Loh, et al.
Published: (2016) -
Effect of preparation methods on tosufloxacin tosylate/ hydroxypropyl-β-cyclodextrin inclusion complex
by: Jianfei Sun, et al.
Published: (2023) -
Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability
by: Chiara Migone, et al.
Published: (2024)